
Temporary Research Associate / Lead Identification Group, Antisense Drug Discovery
Ionis Pharmaceuticals, Inc.
Summary
Ionis Pharmaceuticals, Inc., a leader in RNA-targeted therapy research and drug discovery, seeks a highly motivated individual to join as a Temporary Research Associate (temp position) in the Antisense Lead Identification team. This is a temporary position with a fixed term of 3-6 months. The role will not be extended beyond 6 months or converted to a permanent position and contract renewal is not anticipated. In this temporary position the successful candidate will work as a member of the group responsible for in vitro assay development for screening and characterizing oligonucleotides against novel gene targets.
Job description
Summary
Ionis Pharmaceuticals, Inc., a leader in RNA-targeted therapy research and drug discovery, seeks a highly motivated individual to join as a Temporary Research Associate (temp position) in the Antisense Lead Identification team. This is a temporary position with a fixed term of 3-6 months. The role will not be extended beyond 6 months or converted to a permanent position and contract renewal is not anticipated. In this temporary position the successful candidate will work as a member of the group responsible for in vitro assay development for screening and characterizing oligonucleotides against novel gene targets.
The ideal candidate will have experience in primary and immortalized cells culture and maintenance, with strong aseptic cell culture skills. The candidate should have experience with a broad range of molecular biology techniques and cell-based assays. The candidate should possess a strong work ethic, good communication skills and ideally, experience in an automated high-throughput laboratory environment. The successful candidate will be able to perform the following responsibilities with a high degree of independence and attention to detail.
Responsibilities
Ideal candidate must learn, optimize and meticulously follow preset workflows that have been established to study activity of oligonucleotides. Specific work includes:
- Culture of various mammalian immortalized cell culture systems.
- Ensure maintaining a sterile environment and practicing careful techniques to prevent contamination during cell culture and other downstream processes.
- Perform quality control, feeding, passaging, harvesting and cryopreservation of cells.
- Apply molecular and cell-based assays including but not limited to RNA purification, transfection, and gene expression analysis (RT-qPCR).
- Operate established protocols on automated liquid handling instrumentation and robotics.
- Maintain detailed records of experiments.
Requirements
- B.S./M.S. degree in molecular biology, biology, biochemistry, bioengineering, or related field
- Minimum of 1-2 years' experience working in an academic or industrial laboratory setting
- Experience and demonstrated expertise in mammalian cell culture is essential
- Strong molecular biology and assay development skills
- Prior experience with automated instrumentation/liquid handlers for compound screening is desirable
- Exceptional attention to detail
- Excellent written and verbal communication skills
- Expected to be a self-starter and work productively within a multidisciplinary team under demanding timelines
Company overview
Ionis Pharmaceuticals, Inc. is a pioneering commercial-stage biotechnology company that specializes in discovering and developing RNA-targeted medicines. Founded in 1989 and headquartered in Carlsbad, California, Ionis has established itself as a leader in antisense therapy, RNA interference, and CRISPR therapeutics. The company's innovative approach focuses on modifying RNA to treat a wide range of serious diseases, including neurological disorders, cardiovascular conditions, and rare genetic diseases. Ionis has developed several FDA-approved therapies, including SPINRAZA for spinal muscular atrophy, TRYNGOLZA for familial chylomicronemia syndrome, WAINUA for hereditary transthyretin-mediated amyloidosis, and QALSODY for amyotrophic lateral sclerosis. With a robust pipeline of over 40 investigational medicines in various stages of development, Ionis maintains strategic collaborations with major pharmaceutical companies like Biogen, AstraZeneca, Novartis, and Roche. The company employs approximately 1,069 professionals and continues to advance its mission of delivering transformative medicines that enable better futures for patients living with serious diseases.